Keywords: Eli Lilly, Sun Pharmaceuticals, Gemzar, gemcitabine HCI,

Lilly plans to appeal over Gemzar's intellectual property

Article | 07 September 2009

Print This

US drug major Eli Lilly says that the US District Court for the Eastern District of Michigan has granted a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in